Sorry, I don't understand your search. ×
Back to Search Start Over

Eagle Pharmaceuticals Announces Commercial Availability of Vasopressin

Source :
Business Wire. January 18, 2022
Publication Year :
2022

Abstract

-- Shipment of vasopressin, a generic alternative to Vasostrict([R]),commences today, with 180 days of marketing exclusivity -- -- Product launch expected to drive significant revenue growth in 2022 -- WOODCLIFF [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.689769893